Advanced therapies, such as cell and gene therapies, are transforming healthcare, but manufacturing and development challenges impede their adoption. Cytiva is committed to overcoming these hurdles by optimizing processes and using advanced technologies to speed up the development and production of these therapies. Our expertise spans viral vectors, cell therapies, and RNA-based therapies, supporting the entire development journey from research to commercial manufacturing.